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Background: Data about the risk factors of stroke are sparse in the Middle East populations. We aimed to
determine the potential risk factors and their population attributable fraction (PAF) for stroke in an Iranian
population.
Methods: A cohort Study consisted of 1089 men and 1289 women, with mean (SD) ages of 61.1(7.6) and 59.0(6.7)
years, respectively. Cox regression was implemented to estimate the hazard ratio (HR) of each risk factor for stroke
events in a stepwise method. We calculated a multivariate adjusted population attributable fraction (PAF) for any
risk factors remained in the model.
Results: During 9.3 years of follow-up, 69 events of stroke occurred with incidence rates of 4.5 (95% CI: 3.3-6.0) and
2.5 (1.7-3.6) in 1000 person-years for men and women respectively. Among potential risk factors, only age≥ 65 years
(HR: 2.03, CI: 1.24-3.31), male gender (HR: 2.00, CI: 1.16-3.43), hypertension (HR: 3.03, CI: 1.76-5.22), diabetes mellitus
(HR: 2.18, CI: 1.34-3.56), and chronic kidney disease (CKD) (HR: 2.01, CI: 1.22-3.33), were independently associated
with increased risk of stroke events in the total population. A paired homogeneity test showed that the hazard ratio
of CKD did not differ from other independent risk factors. The PAFs were 29.7% and 25% for male gender and
age≥ 65 as non-modifiable and 48.6%, 29.1% and 22.0% for hypertension, CKD and diabetes as modifiable risk
factors respectively.
Conclusion: Following this population based study of Iranians, we demonstrated that among modifiable risk
factors, CKD as well as hypertension and diabetes are the strongest independent predictors of stroke.
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Stroke is the second leading cause of death worldwide
and the leading cause of functional impairments in
adults which could affects both patients and their rela-
tives in most regions [1,2]. As populations are getting
older, a dramatic increase in prevalence and burden of
disability is expected in the future. In the Middle East
and North Africa (MENA), stroke is progressively be-
coming a major health problem and it is estimated that
its current mortality will double by 2030 [3]. Incidence* Correspondence: fzhadaegh@endocrine.ac.ir
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reproduction in any medium, provided the orrate of stroke and its case fatality rate varies extensively
among studies in this region [4]. In this respect, the
prevention strategies need to be implemented urgently.
Prospective studies have revealed different risk factors
for stroke subtypes [5]. The risk factors for ischemic
stroke include aging, hypertension, diabetes, smoking,
history of cardiovascular diseases (CVD), atrial fibrilla-
tion, and left ventricular hypertrophy [5,6]. The INTER-
STROKE study, involving 22 countries demonstrated
that ten risk factors account for 90% of the population-
attributable risks for stroke events. However, not all po-
tential risk factors were considered in INTERSTROKE
study [7]. Recently, a meta-analysis highlighted the
importance of the independent association between low
glomerular filtration rate and incident stroke [8]. Theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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kidney disease (CKD) on stroke among Asian popula-
tions compared to non-Asian populations.
There is a scarcity of reliable information on the pos-
sible risk factors and population-attributable risks for
stroke in the developing countries, especially in Middle
East region [9]. Also, the incidence rates of regional
stroke and measure of association need to be clarified to
provide optimal treatment and reduce the burden of
stroke. In this study, we aimed to determine the poten-
tial risk factors and their population attributable fraction




Tehran Lipid and Glucose Study (TLGS) is a prospective
population-based cohort study carried out on 15005
people aged, 3 years and over living in district-13 of
Tehran, to ascertain the risk factors for non-
communicable diseases. Subjects were divided into the
cohort and intervention groups, the latter being
instructed on how to modify their life style; the method
of this educational intervention has been described else-
where [10,11]. There were 3394 participants, aged
≥50 years, in the first phase of TLGS (February 1999 to
August 2001). We excluded 435 participants with CVD
history at baseline. After further excluding, 184 subjects
with missing data at baseline and 347 subjects without
any follow-up data, remained 2378 participants (80.4%
of the eligible subjects;) who were followed until 20
March 2009 with a median follow up of 9.3 years. Data
of all these participants including 953 individuals of the
intervention group and 1425 individuals of the cohort
group were pooled for final analysis.
The proposal of this study was approved by the ethical
committee of the Research Institute for Endocrine
Sciences and informed written consent were obtained
from all subjects.
Clinical and laboratory measurements at the baseline
All information was gathered by a trained interviewer,
using a pretested questionnaire which included demo-
graphic data, past medical history, drug consumption
and smoking behavior. Blood pressure and anthropome-
trical measurements were collected during physical
examinations.
After 12 to 14 hours overnight fasting, a blood sam-
ple was taken and fasting plasma glucose (FPG), total
cholesterol (TC), high density lipoprotein cholesterol
(HDL-C), triglyceride (TG) and creatinine levels were
measured on the day of blood sampling at the TLGS
research laboratory. Two hour plasma glucose (2 h-
PG) was also measured in participants without anyknown diabetes. The details of data gathering have
been described before [10].
Definition of terms
We defined the variables studied as follows: Diabetes
mellitus (DM), FPG ≥7 mmol/l, 2 h-PG ≥11.1 mmol/l
or current use of glucose lowering medication; pre-
diabetes i.e. impaired fasting glucose (IFG) or impaired
glucose tolerance (IGT), FPG ≥5.55 mmol/l or 2 h-PG
≥7.77 mmol/l in non-diabetic subjects; hypertension,
systolic blood pressure ≥ 140 mmHg and/or diastolic
blood pressure ≥ 90 mmHg or current use of antihyper-
tensive medication; Pre-hypertension, SBP ≥120 mmHg
or DBP ≥80 mmHg in non-hypertensive subjects;
hypercholesterolemia, TC ≥6.20 mmol/l or using anti
lipid drugs; Low HDL, HDL <1.03 mmol/l; high trigly-
cerides, TG ≥2.258 mmol/l or anti-lipid drug use; gen-
eral obesity, body mass index (BMI) ≥30 kg/m2; central
obesity, waist circumference ≥95 cm in both genders for
an Iranian population[12]; family history of premature
CVD, any prior diagnosis of CVD in male and female
first-degree relatives under 55 and 65 years, respectively;
smoking, current or past use of cigarettes or other
smokes(water-pipes, pipes); Intervention, participants
who were educated to change life style [10].
According to guideline of the Kidney Disease Outcome
Quality Initiative(KDOQI), chronic kidney disease is
defined as either kidney damage or Glomerular Filtration
Rate (GFR) <60 mL/min/1.73 m2 for >3 months [13].
For this study GFR was estimated using the abbreviated
prediction equation, provided by the Modification of
Diet in Renal Disease (MDRD) study as follows:
Abbreviated MDRD study equation:
GFR ¼ 186 SCrð Þ1:154  Ageð Þ0:203
 0:742 if femaleð Þ
In this equation, eGFR (estimated GFR) is expressed
as mL/min per 1.73 m2 and serum creatinine (SCr) is
expressed as mg/dL [14].
Prevalent CKD was considered an eGFR lower than
60 mL/min/1.73 m2 occurring at baseline; this corre-
sponds to stages 3 to 5 CKD based on the KDOQI
guidelines.
Definition of outcome
The data collection process on cardiovascular outcomes
has been published in detail earlier [10]. To summarize,
each year and in a continuous manner, a trained nurse
questioned each participant for any medical event lead-
ing to hospitalization in the past year, using telephone
call; if a related event had occurred, complementary
data were collected by a trained physician during a
home visit or a visit at the hospital. In the case of
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on death certificate or the forensic medicine report) and
if needed a verbal autopsy i.e. a method of finding as
much data as possible about a dead person by asking
questions of the close family and others who can explain
the mode of death and conditions preceding death. Col-
lected data were evaluated by an outcome committee
consisting of a principal investigator, an internist, an
endocrinologist, a cardiologist, an epidemiologist, the
physician who collected the data and other invited
experts, as needed.
Stroke was defined according to the WHO definition
as, "rapidly developing clinical signs of or global disturb-
ance of cerebral function, lasting > 24 hours or leading to
death with no apparent cause other than that of vascular
origin" [15]. Additionally, we used “imaging of an acute
clinically relevant brain injury in patients with fast van-
ishing symptoms” as another criterion of definite stroke.
Possible stroke was defined as onset of an acute focal
neurological deficit with absent imaging that is indicative
of stroke but for which there is insufficient data to estab-
lish whether the symptoms and the period fully qualify
for the WHO definition for definite stroke [3]. Patients
with Transient Ischemic Attack (TIA) may meet the
above definition of possible stroke with the addition that
their symptoms resolve within 24 hours. All cases, re-
gardless of definite or possible stroke or TIA description
were included in the cerebrovascular accident (CVA/
stroke) definition. We classified strokes as ischemic or
hemorrhagic according to all available information from
informant interviews, medical records, and brain im-
aging studies (Computed Tomography and Magnetic
Resonance Imaging).
Statistics
Baseline characteristics for categorical variables were
presented as percentages. Log-Rank test was used to test
the equality of stroke free survival between the levels of
these exposure variables.
Cox proportional hazard regression model was used to
investigate the hazard ratio (HR) of each risk factor.
Time to event was defined as time of censoring or hav-
ing event, whichever came first. We censored individuals
at the time of other causes of death, leaving the resi-
dence area and loss to follow up or being in the study
until March 2009, without any CVA event. The propor-
tional hazard assumption was tested graphically and
using the time-dependent covariate test. All proportion-
ality assumptions were generally appropriate. To detect
the most important risk factors of CVA, a forward step-
wise approach was used (p <0.2 for entry and p >0.1 for
removal). The following covariates were used in the
model: old age (> = 65 y.), sex, hypertension, DM, hyper-
cholesterolemia, high TG, low HDL, general obesity,central obesity, family history of premature CVD, smoking
and CKD; intervention was also considered as a possible
confounder. A modified version of the Hosmer-Lemeshow
chi-square for survival data was used to check the model
fitness [16]. We calculated a multivariate adjusted popu-
lation attributable fraction (PAF) for any risk factors that
remained in the model [17]. A paired homogeneity test,
which is a Wald test of the linear hypothesis of the Cox
model regression coefficients, was performed to test the
null hypothesis that the hazard ratio for CKD was equal
to that for other risk factors in prediction of incident
stroke. To be more specific, the Cox analysis was
repeated for continuous data including age, SBP, DBP,
FPG, TC, TG, HDL-C, BMI, waist circumference and
eGFR besides sex, family history of premature CVD,
smoking and intervention.
Additionally, to find out the role of pre-diabetes and
pre-hypertension in predicting CVA, we compared the
Kaplan-Meier failure rates of these categories.
To increase the study power, we pooled men and
women, because, there was not significant interaction
between sex and other risk factors related to CVA
outcome.
All analyses were carried out using STATA version 10
and statistically significant level was defined as 2-tailed
P-value below than 0.05.
Results
The study sample consisted of 1089 men and 1289
women, with mean (SD) ages of 61.1 (7.6) and 59.0 (6.7)
years, respectively. There was no significant difference
between the followed and non-followed participants with
regards to age and other major risk factors of CVA. Dur-
ing 9.3 years of follow-up, 69 (41 men) cases of stroke
events occurred with an incidence rate of 4.5 (95% CI:
3.3-6.0) and 2.5 (1.7-3.6) in 1000 person-years of men
and women respectively. Most of the cases were ische-
mic stroke and only 3 cases in women and 5 cases in
men were hemorrhagic ones. Incidence rates of stroke
according to the baseline exposure variables are sum-
marized in Table 1. Log-Rank test showed that the
stroke free survival was differed between levels of age,
sex, hypertension, DM, smoking and CKD exposure
variables. These variables, whether examined as continu-
ous or binary, were the most important risk factors of
CVA based on the stepwise Cox proportional hazard
model as well (Table 2). Hypertension with a HR of 3.03
(1.76- 5.22) and smoking with HR of 1.63 (0.94- 2.80)
had the highest and the lowest significant HRs respect-
ively. The other significant risk factors had a HR of
around two. Paired homogeneity test showed that the
hazard ratio of CKD was not different from other inde-
pendent risk factors (all p >0.2). The Hosmer-Lemeshow
test was non-significant (p = 0.4) indicating goodness of
Table 1 Incidence rates of stroke according to the baseline exposure variables
Exposure variable No. (%) Total: 2378 Incidence (95%CI) * Exposure + Incidence (95%CI) * Exposure − P- Value†
Age, ≥ 65 645 (27.1) 6.6 (4.7-9.2) 2.3 (1.7-3.2) < 0.001
Sex, male 1089 (45.8) 4.5 (3.3-6.0) 2.5 (1.7 -3.6) 0.017
Hypertension 1057 (44.4) 5.6 (4.3 -7.4) 1.7 (1.1-2.6) < 0.001
Diabetes 544 (22.9) 6.3 (4.4-9.1) 2.6 (1.9-3.5) < 0.001
Smoking 548 (23.0) 5.1 (3.4-7.7) 2.9 (2.2-3.9) 0.020
Obesity 707 (29.7) 3.4 (2.2-5.2) 3.4 (2.5-4.5) 0.995
High WC 1121 (47.1) 4.1 (3.0-5.6) 2.8 (1.9-4.0) 0.102
Low HDL-C 1062 (44.7) 3.5 (2.5-5.0) 3.3 (2.4-4.5) 0.732
Hypertriglyceridemia 955 (40.2) 4.1 (3.0-5.8) 2.9 (2.1-4.0) 0.134
Hypercholesterolemia 1017 (42.8) 3.4 (2.4-4.9) 3.3 (2.4-4.6) 0.906
Intervention 953 (40.1) 3.4 (2.3-4.9) 3.4 (2.5-4.6) 0.987
FH CVD 363 (15.3) 4.2 (2.4 -7.2) 3.2 (2.5-4.2) 0.410
CKD 964 (40.5) 5.0 (3.6-6.8) 2.4 (1.6-3.4) 0.001
*Incidence density per 1000 person-years.
†Based on Log Rank test for equality of stroke free survival between exposure-positive and exposure-negative groups.
CI: confidence interval; WC: waist circumference; HDL-C: HDL cholesterol; Intervention: being in the intervention group; FH CVD: family history of premature
cardiovascular disease; CKD: chronic kidney disease.
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male gender and age ≥ 65 as non-modifiable and 48.6%,
29.1% and 22.0% for hypertension, CKD and diabetes re-
spectively as modifiable risk factors (Table 2). TheTable 2 Risk factors of stroke and their Population
Attributable Fraction based on Cox proportional hazard
model*
HR 95% CI P-value PAF (%)
Model including binary variables
Age, ≥ 65 years 2.03 (1.24- 3.31) 0.005 25.0
Sex, male 2.00 (1.16- 3.43) 0.012 29.7
Smoking 1.63 (0.94- 2.80) 0.081 12.9
Hypertension 3.03 (1.76- 5.22) < 0.001 48.6
Diabetes 2.18 (1.34- 3.56) 0.002 22.0
Chronic Kidney Disease 2.01 (1.22- 3.33) 0.007 29.1
Model including continuous variables
Age, year 1.08 (1.04-1.11) < 0.001
Sex, male 1.74 (1.02-2.98) 0.044
Smoking 1.75 (1.02-3.01) 0.042
Systolic blood pressure, cmHg 1.13 (1.00-1.28) 0.045
Diastolic blood pressure, cmHg 1.55 (1.21-1.98) 0.001
Fasting plasma glucose, mmol/l 1.10 (1.01-1.18) 0.021
GFR, mL/min/1.73 m2 0.97 (0.95-0.99) 0.008
* These risk factors remained in the model through a forward stepwise
method; other variables (obesity, high waist circumference, low HDL
cholesterol, hypertriglyceridemia, hypercholesterolemia, intervention and
family history of premature cardiovascular disease) excluded from the model
because of p < 0.2 for entry or p > 0.1 for removal. Hosmer-Lemeshow chi-
square (modified version for survival data) was <20 indicating a good fitness
of the model.
HR: Hazard Ratio; CI: Confidence Interval; PAF: Population Attributable Fraction;
GFR: Glomerular Filtration Rate.results did not change when our analysis limited to those
with ischemic stroke as the outcome (Table 3).
Kaplan-Meier failure rate and Log-Rank test showed
no difference between pre-diabetic and non-diabeticTable 3 Risk factors of Ischemic stroke and their
Population Attributable Fraction based on Cox
proportional hazard model*
HR 95% CI P-value PAF (%)
Model including binary variables
Age, ≥ 65 years 2.04 (1.21- 3.44) 0.007 24
Sex, male 1.93 (1.90- 3.43) 0.024 28.4
Smoking 1.73 (0.97- 3.08) 0.063 14.5
Hypertension 2.73 (1.55- 4.81) 0.001 44.7
Diabetes 2.38 (1.42- 3.99) 0.001 24.7
Chronic Kidney Disease 2.09 (1.22- 3.58) 0.007 30.8
Model including continuous variables
Age, years 1.07 (1.03-1.11) <0.001
Sex, male 1.69 (0.95-3.00) 0.072
Smoking 1.83 (1.04-3.25) 0.038
Systolic blood pressure, cmHg 1.13 (0.99-1.28) 0.075
Diastolic blood pressure, cmHg 1.51 (1.16-1.96) 0.002
Fasting plasma glucose, mmol/l 1.11 (1.03-1.20) 0.009
GFR, mL/min/1.73 m2 0.97 (0.94-0.99) 0.014
* These risk factors remained in the model through a forward stepwise
method; other variables (obesity, high waist circumference, low HDL
cholesterol, hypertriglyceridemia, hypercholesterolemia, intervention and
family history of premature cardiovascular disease)were excluded from the
model because of p < 0.2 for entry or p > 0.1 for removal. Hosmer-Lemeshow
chi-square (modified version for survival data) was <20 indicating a good
fitness of the model.
HR: Hazard Ratio; CI: Confidence Interval; PAF: Population Attributable Fraction;
GFR: Glomerular Filtration Rate.
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normotensive subjects (p = 0.102) regarding CVA out-
come (Figure 1).
Discussion
To the best of our knowledge, this is the first study con-
ducted in the Middle East region reporting the population
attributable fraction for stroke events. Results from this




























































Figure 1 Incidence rates of stroke events regarding different categorpopulations can be attributed to modifiable risk factors of
hypertension, CKD and diabetes. There was no difference
between CKD, hypertension and diabetes, with regard to
the prediction of total as well as ischemic stroke events.
The INTERSTROKE study was the first large case–
control study aimed at ascertaining risk factors for
stroke, in which low and middle income countries like
Iran were included [7]. The study showed that five estab-
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tivity) account for 80% cases of stroke events. With
addition of five other risk factors (diabetes, alcohol in-
take, psychosocial factors, cardiac causes and ApoA1),
the population-attributable risks for stroke reached 90%,
a finding which indicated that there are some other risk
factors that need to be considered beyond these poten-
tial risk factors, bearing in mind that usually the sum of
PAFs goes beyond than 100% [18].
Since, CKD and CVD often shared the same patho-
physiological mechanism [19] and most of those who had
CKD died because of their CVD problems not progres-
sion to end stage renal failure, much attention is being
paid to the magnitude of relationship between CKD and
stroke [20]. In our dataset, we demonstrated the import-
ance of CKD as the second strongest predictor of stroke.
CKD, independent of age, gender, smoking, hypertension
and diabetes, was associated with ischemic stroke and
accounts for 30% of all stroke patients. Importantly, we
found the same risk for CKD vs. other independent risk
factors in prediction of incident stroke; obviously, the
higher PAF of hypertension compared with CKD was
related more to higher prevalence of the former than to
the latter in our population. Recently in a meta-analysis
of 21 articles, Lee et al [8] showed that patient with base-
line eGFR<60 ml/min/1.73 m2 had 43% higher chance of
developing stroke events than those with baseline
eGFR>90 ml/min/1.73 m2; however, they did not find
significant increase risk of stroke among patients with
eGFR of 60-90 ml/min/1.73 m2. They also demonstrated
that the effect of reduced eGFR was more profound on
risk of fatal stroke than all other types of stroke, which is
in line with the fact that kidney disease even with mild se-
verity is independently associated with poor prognosis in
patients with stroke disease resulting in higher risk of
death [8]. It has been also measured that those with low
GFR had smaller brain volume, smaller deep white matter
volume and more white matter layer and these associa-
tions were independent of cardiovascular risk factors [21].
Hypertension is known to be the single most important
risk factor for all kinds of stroke. In an overview of
reviews, Lawes et al documented a continuous steep and
log linear association between blood pressure and stroke
[22]; they also highlighted a 10 mmHg lower SBP or
5 mmHg lower DBP to be associated with 30-40% lower
risk of stroke. In the current study, among modifiable and
non-modifiable risk factors, hypertension showed the
greatest PAF for total as well as ischemic stroke events.
Consistent with previous studies, in our population,
diabetes independently increased the risk of stroke
event. The PAF of 24% of diabetes for ischemic stroke in
the current study was in the range of 5–27% reported in
Goldstein et al study [6]. Despite the significant risk of
diabetes for stroke events, no strong benefit in strokereduction with tight glycemic control has been shown
[23]. However, control of blood pressure in patients with
type 2 diabetes as part of a complete cardiovascular risk-
reduction program and treatment of adults with diabetes
with a statin, especially those with additional risk factors,
is recommended to lower risk of a first stroke [24].
In the current study, smoking showed 73% risk for in-
cident ischemic stroke, which was marginally significant
and leading to PAF of 14% for incident stroke. Similarly,
Goldstein et al recently reported that among risk factors
for incident stroke, smoking showed a PAF of 12 to 14%
[6]. A meta-analysis of 32 studies reported the relative
risk for ischemic stroke to be 1.9 (95% CI, 1.7 to 2.2) for
smokers compared with nonsmokers [25].
In this study, we failed to detect any relationship be-
tween high TG, low HDL and hypercholesterolemia with
stroke events. There are still ongoing debates about the
role of lipid components in the risk of stroke event and
epidemiologic findings are not consistent [26]. Recently,
a meta-analysis of 61 prospective studies, showed a weak
association between lipid profiles and stroke events [27].
They found that the association between serum choles-
terol and stroke mortality was modified by age and
blood pressure levels, whereas no association was
observed between serum cholesterol and stroke, except
in individuals aged 40-59y and in participants with nor-
mal or high normal blood pressure. Also, most but not
all the epidemiologic studies have found a reverse associ-
ation between hemorrhagic stroke and level of blood
cholesterol [28].
An important strength of our study was that, we used
a population based cohort study to determine the risk
factors of stroke and reached a model with good fitness
in our analysis, indicating that we had considered the
main risk factors in our models with acceptable low resi-
duals; some of our limitations however, merit mention-
ing; first due to the limited number of our stroke events,
we were unable to separately analyze and assess the risk
factors for hemorrhagic stroke. Wu et al [29] had con-
cluded that the risk factors of stroke subtypes differ as
they had have different etiopathologies. Second, in the
current study, also as reported from other studies in Iran
[3,9], we might fail to detect all cerebrovascular events
in district 13 of Tehran because there are different types
of public and private healthcare systems in Iran, and the
public hospitals are not completely free of charge; hence
some of people who do not have any type of healthcare
insurance might being managed in outpatient clinics and
not be admitted to hospital. Furthermore, despite a re-
ferral healthcare structure in Iran, there may be situa-
tions where people bypass a primary care contact and
self-refer to private specialists [3,9]. Third, we analyzed
the associations between risk factors and stroke events
from a single measurement at baseline, which may have
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contributing to the attenuation between the risk factors
and incident stroke.
Conclusions
In a population based study in Iran, we have demon-
strated that among modifiable risk factors, CKD as well
as hypertension, diabetes and smoking are the strongest
independent predictors of ischemic stroke. Targeted
interventions that prevent hypertension, CKD, and dia-
betes and promote smoking cessation in current smokers
could largely lessen the burden of stroke events in Iran.
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